C12N 2502/025
Extra-embryonic cells
Official title: extra-embryonic cells, e.g. amniotic epithelium, placental cells, Wharton's jelly
C12N2502/025 (Extra-embryonic cells) appears on 65 US grants and 144 published applications in this corpus.
Search patents in C12N- Granted patents
- 65
- Published applications
- 144
- Assignees
- 59
- Inventors
- 210
- Latest grant
- 14 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 1 |
| 2007 | 0 | 2 |
| 2008 | 0 | 3 |
| 2009 | 0 | 2 |
| 2010 | 1 | 2 |
| 2011 | 2 | 9 |
| 2012 | 0 | 9 |
| 2013 | 2 | 6 |
| 2014 | 1 | 8 |
| 2015 | 7 | 9 |
| 2016 | 7 | 8 |
| 2017 | 3 | 9 |
| 2018 | 2 | 8 |
| 2019 | 7 | 4 |
| 2020 | 4 | 11 |
| 2021 | 4 | 9 |
| 2022 | 4 | 13 |
| 2023 | 5 | 9 |
| 2024 | 4 | 8 |
| 2025 | 6 | 7 |
| 2026 | 6 | 7 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Artificial placenta and methods of preparation14 Jul 2026US 12,680,065 B2The Trustees of the University of Pennsylvania
- Methods for treating an immune disorder-related disease by reducing autoreactivity in a T cell compartment9 Jun 2026US 12,649,905 B2Hackensack University Medical Center
- Methods, culture medias and devices for generating embryos in vitro from stem cells5 May 2026US 12,618,830 B2California Institute of Technology
- Mitochondria-enriched genetically engineered cells and uses thereof21 Apr 2026US 12,605,410 B2Minovia Therapeutics Ltd.
- Cell population comprising mesenchymal cells, pharmaceutical composition comprising the same, and method for producing the same3 Mar 2026US 12,564,607 B2Kaneka Corporation
- Pluripotent stem cell that can be isolated from body tissue1 Oct 2026US 2026/0297512 A1MuseCell Innovations Pte. Ltd.
- Method for culturing muscle-derived cells, and culturing device containing muscle-derived cells6 Aug 2026US 2026/0226415 A1IntegriCulture Inc.
- Methods, culture medias and devices for generating embryos in vitro from stem cells23 Jul 2026US 2026/0210944 A1California Institute of Technology
- Immunocompatible chorionic membrane products28 May 2026US 2026/0144824 A1Osiris Therapeutics, Inc.
- Bovine blastocyst like structures and uses thereof14 May 2026US 2026/0132373 A1
Most cited
By later US patents
- Tumor suppression using placental stem cells57US 7,993,918 B2Anthrogenesis Corporation · 2011
- Co-culture of placental stem cells and stem cells from a second source52US 7,700,090 B2Anthrogenesis Corporation · 2010
- Methods of manufacture of therapeutic products comprising vitalized placental dispersions24US 9,956,248 B2Osiris Therapeutics, Inc. · 2018
- Immunocompatible amniotic membrane products15US 10,272,116 B2Osiris Therapeutics, Inc. · 2019
- Methods of manufacture of immunocompatible amniotic membrane products14US 10,576,104 B2Osiris Therapeutics, Inc. · 2020